Solventum Corporation (SOLV)
Solventum Corporation operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Eagan, MN, US. The stock last traded at $83.91, down 0.23% on the session, giving a market capitalisation of $14.53B. On trailing twelve-month figures it carries a trailing P/E of 10.21, a net margin of 17.3%. Its beta of 0.67 implies it has historically moved less than the broad market.
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
Solventum Corporation is most often compared with the following Healthcare names: